Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

NCT01582035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: TMC647055
DRUG: TMC647055
DRUG: TVR
DRUG: TVR
DRUG: TVR
DRUG: PegFN
DRUG: RBV

Sponsor

Janssen R&D Ireland